arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Abpro Holdings, Inc.

ABPO
Price unavailable
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
6 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Bullish
auto_awesome

Analytical Summary

Abpro Holdings, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin
ROIC 75.6%
FCF / Share $-2.69
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

6-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$183.00K
↑ +50.0%
Net Income Profit after all expenses
$-2.89M
↑ +60.0%
FCF / Share Free cash flow per share
$-2.69
↓ -597.4%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
94
Financial Health
7
Cash Quality
87

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 21 quarters